 |
(+/-)-cis-3-(4-hydroxyphenyl)-4-(4-methoxyphenyl)-3,4-dihydro-2H-cromen-7-ol |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2008-01-10 00:00:00 |
| Sponsor | Marshall Edwards, Inc.;11975 El Camino Real, Suite 101;San Diego, California, 92130 |
